A cancer diagnosis usually begins with a biopsy, imaging and pathology examination. However, in many cancers, these investigations may not provide all the information needed to select the most appropriate treatment.
Molecular testing helps doctors understand the biological characteristics of a tumour by identifying specific genetic changes and biomarkers.
It has become an important part of modern cancer diagnosis and treatment planning.
What Is Molecular Testing?
Molecular testing refers to laboratory investigations that examine DNA, RNA, proteins or other molecular features associated with cancer.
These tests can identify changes that influence how cancer cells grow, divide and respond to treatment.
For example, some lung cancers contain EGFR mutations, while certain breast cancers show increased HER2 protein expression.
Identifying these features may help doctors select appropriate targeted treatments.
Why Is Molecular Testing Performed?
Molecular testing may help:
- Identify mutations associated with tumour growth.
- Determine eligibility for certain targeted medicines.
- Assess suitability for selected immunotherapies.
- Provide additional diagnostic information.
- Identify inherited cancer-related mutations when appropriate.
- Support treatment decisions in advanced cancer.
Common Types of Molecular Tests
1. EGFR Testing
Used in selected lung cancers to identify mutations that may help guide targeted treatment.
2. HER2 Testing
Helps identify HER2-positive cancers that may benefit from HER2-directed treatment.
3. BRCA Testing
Identifies BRCA1 and BRCA2 alterations. Testing may be performed on tumour tissue or blood, depending on whether inherited or tumour-specific changes are being investigated.
4. MSI and MMR Testing
Helps identify microsatellite instability and mismatch repair deficiency, which can influence treatment decisions.
5. ALK and ROS1 Testing
Important in identifying selected molecular subtypes of non-small cell lung cancer.
6. NGS Testing
Next-generation sequencing can examine multiple genes simultaneously and identify potentially actionable molecular changes.
How Is Molecular Testing Performed?
Depending on the test, doctors may use:
- Tissue obtained through a biopsy.
- Surgical tumour samples.
- Blood samples.
- Other appropriate biological specimens.
The choice depends on cancer type, sample availability and the clinical question being investigated.
Does Every Cancer Patient Need Molecular Testing?
No. The requirement depends on the cancer type, stage, treatment setting and available clinical evidence.
Some cancers have established biomarker tests that are routinely recommended, while broader molecular profiling may be considered in selected situations.
Understanding Your Molecular Test Report
A molecular report can contain several findings. Not every detected mutation is clinically important, and not every mutation has an available targeted treatment.
A medical oncologist interprets the results alongside pathology, imaging, disease stage and the patient’s medical history.
Consult Dr. Ayush Dubey – Medical Oncologist in Raipur
Patients with cancer may benefit from discussing appropriate molecular investigations with their treating specialist.
Dr. Ayush Dubey provides medical oncology consultation and guidance on understanding cancer reports and treatment options.
Molecular testing can provide valuable information, but the right test is the one that can meaningfully guide a patient’s care.